A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
V
Vaccination — see Immunization
Vaccination and Pregnancy — see Pregnancy and Vaccination
Vaccination, American Indian and Alaska Native — see American Indian and Alaska Native Vaccination
Vaccine Adverse Event Reporting System (VAERS)
Vaccine Information Statements (VIS)
Vaccine Ingredients
Vaccine Management System (VACMAN)
Vaccine Recalls, Questions About — see Questions about Vaccine Recalls
Vaccine Safety
Vaccine Safety (Emergency Preparedness) — see Emergency Preparedness (Vaccine Safety)
Vaccine Safety Concerns
Vaccine Safety for Measles, Mumps, Rubella, Varicella (MMRV) — see Measles, Mumps, Rubella, Varicella (MMRV) Vaccine Safety
Vaccine Safety, Intussusception and Rotavirus Vaccine — see Rotavirus Vaccine & Intussusception
Vaccine Side Effects
Vaccine Tracking System (VTrckS)
Vaccine-Preventable Diseases and Specific Vaccines
Vaccines — see Immunization
Vaccines and Sudden Infant Death Syndrome (SIDS) — see Sudden Infant Death Syndrome (SIDS) and Vaccines
Vaccines and Thimerosal (Mercury) — see Thimerosal (Mercury) and Vaccines
Vaccines for Children Program — see VFC Program
Vaccines, Testing and Monitoring — see Testing and Monitoring Vaccines
VACMAN (Vaccine Management System)
VAERS (Vaccine Adverse Event Reporting System)
Vaginal and Vulvar Cancers
Vaginal Candidiasis — see Genital Candidiasis
Valley Fever [Coccidioidomycosis]
Vancomycin-Intermediate/Resistant Staphylococcus aureus Infections [VISA/VRSA]
Vancomycin-resistant Enterococci Infection (VRE)
VAP (Ventilator-associated pneumonia)
Variant Creutzfeldt-Jakob Disease (vCJD)
Variant Viruses - see Influenza
Varicella Disease — see Chickenpox
Varicella Vaccination — see Chickenpox Vaccination
Varicella Zoster Virus (VZV) — see Shingles
Varicella-Zoster Virus Infection
Variola Major Virus Infection — see Smallpox
Variola Minor Virus Infection — see Smallpox
vCJD (Variant Creutzfeldt-Jakob Disease)
Vehicle Safety
Venezuela
Venomous Snakes
Venomous Spiders
Venous Thromboembolism (VTE)
see also Blood Clots
Ventilator-associated pneumonia (VAP)
Vermiculite
verruga peruana — see Carrión’s disease
Vessel Sanitation and Health — see Cruise Ship Sanitation
Veterinary Safety and Health
Veterinary Students, Epidemiology Elective Program for — see Epidemiology Elective Program for Senior Medical and Veterinary Students
VFC Program [Vaccines for Children Program]
VHF (Viral Hemorrhagic Fevers)
Vibration
Vibrio cholerae Infection — see Cholera
Vibrio Illness [Vibriosis]
Vibriosis — see Vibrio Illness
Video — see CDC TV
Vietnam
Violence
Violence, Occupational — see Workplace Violence
Viral Hemorrhagic Fevers (VHF)
Alkhurma hemorrhagic fever (AHF)
Chapare Hemorrhagic Fever (CHHF)
Crimean-Congo hemorrhagic fever (CCHF) [Nairovirus Infection]
Ebola Virus Disease (EVD)
Hantavirus Pulmonary Syndrome (HPS)
Kyasanur Forest disease (KFD)
Lassa Fever
Lujo Hemorrhagic Fever (LUHF)
Marburg Hemorrhagic Fever
Omsk hemorrhagic fever (OHF)
Rift Valley Fever (RVF)
Viral Hepatitis
Viral Meningitis [Aseptic Meningitis]
see also Meningitis [Meningococcal Disease]
Virtual Platform Initiative (VPI)
VIS (Vaccine Information Statements) — see Vaccine Information Statements (VIS)
VISA/VRSA — see Vancomycin-Intermediate/Resistant Staphylococcus aureus Infections
Vision and Mission, CDC — see CDC Mission and Vision
Vision Health Initiative — see Eye and Vision Health
Vision Impairment
Visitors Center
Vital and Health Statistics Reports (Rainbow Series)
Vital Records
Vital Signs
Vital Signs Town Hall Conferences
Vitamins
Volcanoes
Von Willebrand Disease — see VWD
VPD Surveillance Manual — see Manual for the Surveillance of Vaccine-Preventable Diseases
VPI (Virtual Platform Initiative)
VRE (Vancomycin-resistant Enterococci Infection)
VTE (Venous Thromboembolism)
VTrckS (Vaccine Tracking System)
Vulnerable — see Social Vulnerability Index
Vulvovaginal Candidiasis — see Genital Candidiasis
VVC (Genital Candidiasis)
VWD [Von Willebrand Disease]
VX
VZV (Varicella Zoster Virus) — see Shingles
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Content source:
Page maintained by:
Office of the Associate Director for Communication, Division of Public Affairs
TOP